Researcher.Life Logo

Antibiotics : Impact Factor & More

eISSN: 2079-6382pISSN: 2079-6382
JournalOpen Access

Key Metrics

CiteScore
3
Scite Index
0.88 5-Year SI
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Antibiotics

Antibiotics Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Multidisciplinary Digital Publishing Institute (MDPI)
Language English
Frequency Quarterly
Article Processing ChargesCHF 2000
Publication Time6
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Antibiotics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Antibiotics

When Hours Matter: A 24/7 Laboratory and Fast-Track Diagnostic Pathway for Blood Cultures in Critical Patients
  • 23 Apr 2026
  • Antibiotics
Routine Susceptibility Testing of Helicobacter pylori in Clinical Practice—Results of a Prospective Multicentre Study
  • 23 Apr 2026
  • Antibiotics
Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature Review
  • 22 Apr 2026
  • Antibiotics
Prescribing Patterns and Clinical Effectiveness of Ceftolozane/Tazobactam for ESBL-Producing Enterobacterales: A SPECTRA Real-World Multi-Country Analysis
  • 22 Apr 2026
  • Antibiotics
How Glyphosate and Its Derivatives Influence Antimicrobial Resistance Emergence and Transmission: A One Health Perspective.
  • 21 Apr 2026
  • Antibiotics (Basel, Switzerland)
Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.
  • 21 Apr 2026
  • Antibiotics (Basel, Switzerland)
When Hours Matter: A 24/7 Laboratory and Fast-Track Diagnostic Pathway for Blood Cultures in Critical Patients
  • 23 Apr 2026
  • Antibiotics
Routine Susceptibility Testing of Helicobacter pylori in Clinical Practice—Results of a Prospective Multicentre Study
  • 23 Apr 2026
  • Antibiotics
Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature Review
  • 22 Apr 2026
  • Antibiotics
Prescribing Patterns and Clinical Effectiveness of Ceftolozane/Tazobactam for ESBL-Producing Enterobacterales: A SPECTRA Real-World Multi-Country Analysis
  • 22 Apr 2026
  • Antibiotics
How Glyphosate and Its Derivatives Influence Antimicrobial Resistance Emergence and Transmission: A One Health Perspective.
  • 21 Apr 2026
  • Antibiotics (Basel, Switzerland)
Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.
  • 21 Apr 2026
  • Antibiotics (Basel, Switzerland)

FAQs on Antibiotics